Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alma Martelli

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
European Journal of Medicinal Chemistry|October 13, 2006
Structural modifications of benzanilide derivatives, effective potassium channel openers. XVincenzo Calderone, Alessio Coi, Francesca Lidia Fiamingo, et al.
Journal of Medicinal Chemistry|December 22, 2006
New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic propertiesMaria C Breschi, Vincenzo Calderone, Alma Martelli, et al.
Vascular Pharmacology|November 30, 2013
Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?Alma Martelli, Lara Testai, Valentina Citi, et al.
RSC Medicinal Chemistry|January 29, 2024
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying <i>in vivo</i> cardioprotective activitiesGiulia Bononi, Valentina Citi, Alma Martelli, et al.
International Journal of Molecular Sciences|December 11, 2022
Resveratrol-like Compounds as SIRT1 ActivatorsLidia Ciccone, Eugenia Piragine, Simone Brogi, et al.
BMC Pharmacology & Toxicology|May 15, 2023
Analysis of the relation between adverse events and overall survival in patients treated with pembrolizumab as a first-line treatment for metastatic NSCLCLisa Faoro, Adriana Brusegan, Alberto Russi, et al.
European Journal of Medicinal Chemistry|October 5, 2019
Design and synthesis of H<sub>2</sub>S-donor hybrids: A new treatment for Alzheimer's disease?Simona Sestito, Letizia Pruccoli, Massimiliano Runfola, et al.
British Journal of Pharmacology|August 13, 2020
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H<sub>2</sub> S donors in COVID-19 therapyValentina Citi, Alma Martelli, Vincenzo Brancaleone, et al.
Phytotherapy Research : PTR|December 16, 2025
Harnessing Moringa oleifera Lam's Isothiocyanates for Targeted H<sub>2</sub>S Delivery: A Systematic Review of the LiteratureMaria Ponticelli, Rosangela Montanaro, Vincenzo Calderone, et al.
Journal of Medicinal Chemistry|February 14, 2009
Enantioselectivity in cardioprotection induced by (S)- (-)-2,2-dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromaneSimona Rapposelli, Vincenzo Calderone, Roberto Cirilli, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
European Journal of Medicinal Chemistry|October 13, 2006
Structural modifications of benzanilide derivatives, effective potassium channel openers. XVincenzo Calderone, Alessio Coi, Francesca Lidia Fiamingo, et al.
Journal of Medicinal Chemistry|December 22, 2006
New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic propertiesMaria C Breschi, Vincenzo Calderone, Alma Martelli, et al.
Vascular Pharmacology|November 30, 2013
Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?Alma Martelli, Lara Testai, Valentina Citi, et al.
RSC Medicinal Chemistry|January 29, 2024
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying <i>in vivo</i> cardioprotective activitiesGiulia Bononi, Valentina Citi, Alma Martelli, et al.
International Journal of Molecular Sciences|December 11, 2022
Resveratrol-like Compounds as SIRT1 ActivatorsLidia Ciccone, Eugenia Piragine, Simone Brogi, et al.
BMC Pharmacology & Toxicology|May 15, 2023
Analysis of the relation between adverse events and overall survival in patients treated with pembrolizumab as a first-line treatment for metastatic NSCLCLisa Faoro, Adriana Brusegan, Alberto Russi, et al.
European Journal of Medicinal Chemistry|October 5, 2019
Design and synthesis of H<sub>2</sub>S-donor hybrids: A new treatment for Alzheimer's disease?Simona Sestito, Letizia Pruccoli, Massimiliano Runfola, et al.
British Journal of Pharmacology|August 13, 2020
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H<sub>2</sub> S donors in COVID-19 therapyValentina Citi, Alma Martelli, Vincenzo Brancaleone, et al.
Phytotherapy Research : PTR|December 16, 2025
Harnessing Moringa oleifera Lam's Isothiocyanates for Targeted H<sub>2</sub>S Delivery: A Systematic Review of the LiteratureMaria Ponticelli, Rosangela Montanaro, Vincenzo Calderone, et al.
Journal of Medicinal Chemistry|February 14, 2009
Enantioselectivity in cardioprotection induced by (S)- (-)-2,2-dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromaneSimona Rapposelli, Vincenzo Calderone, Roberto Cirilli, et al.
Pageof 16